[Calorigenic action of dopamine and dobutamine]

Area of Science:

• Pharmacology
• Physiology
• Neuroscience

Background:

• Sympathomimetic drugs, including dopamine and dobutamine, are known to influence metabolic rate.
• Understanding the calorigenic effects of these agents and their modulation by neuronal uptake is crucial for their therapeutic application.
• Desipramine is a selective norepinephrine reuptake inhibitor, offering a tool to investigate neuronal interactions.

Purpose of the Study:

• To investigate the calorigenic actions of dopamine and dobutamine in narcotized rats.
• To examine the influence of desipramine pretreatment on the calorigenic effects of dopamine, dobutamine, and noradrenaline.

Main Methods:

• Subcutaneous administration of dopamine, dobutamine, and noradrenaline to narcotized rats.
• Pretreatment with desipramine to assess its modulatory effects on calorigenesis.
• Quantification of calorigenic responses and assessment of onset and duration of action.

Main Results:

• Dopamine and dobutamine demonstrated significant calorigenic actions.
• Dobutamine's efficacy was comparable to noradrenaline, while dopamine was approximately five times less potent.
• Desipramine pretreatment potentiated noradrenaline's calorigenic effect, accelerated its onset and offset, but did not affect dobutamine's rapid action and reduced dopamine's calorigenic effect.

Conclusions:

• Dopamine and dobutamine possess notable calorigenic properties in vivo.
• The differing effects of desipramine suggest distinct neuronal uptake and metabolic pathways for dopamine, dobutamine, and noradrenaline.
• These findings highlight the importance of neuronal reuptake in modulating the in vivo actions of sympathomimetic drugs.